https://www.selleckchem.com/pr....oducts/evobrutinib.h
46, 6.22], P=0.003); Meta-regression showed that the association between coronary heart disease and poor prognosis of COVID-19 was affected by hypertension (P=0.004), and subgroup analysis showed that compared with the proportion of hypertension 30% (OR=2.85, 95%CI [2.33, 3.49]), the proportion of hypertension 30% (OR=4.78, 95%CI [3.50, 6.51]) had a higher risk of poor prognosis. Coronary heart disease is a risk factor for poor prognosis in patients with COVID-19. Coronary heart disease is a risk factor for poor prognosis in
Gefällt mir
Kommentar
Teilen
